Search for: "Federal Trade Commission v. Qualcomm Inc." Results 1 - 20 of 59
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Aug 2020, 9:59 pm by Patent Docs
Noonan -- The Federal Trade Commission has a history of taking positions and aggressively pursuing them, despite getting reversed (sometimes continually) by Circuit Courts (see "Reverse Payments in Generic Drug Settlements"), although occasionally finding an ally in the Supreme Court (see "Federal Trade Commission v. [read post]
7 Nov 2018, 7:05 am by Dennis Crouch
Cal. 2018) In an important decision, Judge Koh granted partial summary judgment for the Federal Trade Commission (FTC) that will require Qualcomm to license its Standard-EssentialPatents (SEPs) for 3G Mobile (and other) communication standards on fair, reasonable, and nondiscriminatory (FRAND) terms. [read post]
10 Feb 2019, 10:00 pm by Florian Mueller
Samsung used to be a party to the proceedings relating to the 2016 decision, but dropped out after effectively settling its dispute with Qualcomm throuhg a new commercial deal in 2018 that involved not only patent licenses but also the use of Samsung's foundry by Qualcomm.Testimony from Samsung and LG, and documents referring to Samsung and LG, also played a role in last month's U.S. antitrust trial (Federal Trade Commission v. [read post]
16 Oct 2008, 11:11 am
International Trade Commission (October 14, 2008), the Federal Circuit vacated and remanded the ITC's determination of induced infringement for failing to examine whether Qualcomm's conduct satisfied the specific intent requirement.The decision noted that the Commission found Qualcomm's MSM chips infringe the '983 Patent's asserted claims when they are programmed with computer source code ("system determination… [read post]
10 Sep 2020, 7:25 am by Jason Rantanen
  Abstract: On August 11, 2020, the Ninth Circuit handed down its opinion in Federal Trade Commission v. [read post]
3 Dec 2019, 10:16 pm by Bona Law PC
Brief of the United States and the Federal Trade Commission as Amici Curiae Supporting Plaintiffs-Appellees, Teladoc, Inc. v Texas Medical Board, No. 16-50017 (5th Cir. filed Sept. 9, 2016). [read post]
28 May 2010, 12:08 pm by Tom Fisher
On June 9, 2010, the Federal Circuit is scheduled to hear oral argument in Spansion, Inc. v. [read post]
22 Nov 2019, 9:36 pm by Florian Mueller
Late on Friday, the Federal Trade Commission (FTC) filed its answering brief to Qualcomm's appeal (this post continues below the document):19-11-22 FTC Answering Brie... by Florian Mueller on ScribdThe part I'm most interested in--as always in this context--is chipset-level licensing. [read post]
24 Sep 2021, 4:12 am by Merpel McKitten
In the Federal Trade Commission’s litigation against Qualcomm, Judge Koh addressed the first argument on a summary judgment motion, concluding that Qualcomm’s FRAND commitments under the Telecommunications Industry Association (TIA) and Alliance for Telecommunications Industry Solutions (ATIS) Intellectual Property Rights (IPR) policies require Qualcomm to license its SEPs to modem chip suppliers. [read post]
26 Nov 2019, 8:50 am by Florian Mueller
In its answering brief to Qualcomm's Ninth Circuit antitrust appeal, the Federal Trade Commission (FTC) downplays the importance of Judge Lucy H. [read post]
27 Dec 2010, 8:44 am by Eric Schweibenz
On December 21, 2010, the Federal Circuit issued its opinion in Spansion, Inc. v. [read post]
9 Jul 2013, 6:31 am by Florian Mueller
Sept. 12, 2007) (granting stay requested by wireless carriers and handset manufacturers);Dynatec Int'l, Inc. v. [read post]
7 Oct 2021, 4:20 am by Annsley Merelle Ward
For example, in Qualcomm’s 2019 Ninth Circuit opening brief in its litigation against the Federal Trade Commission, Qualcomm contended its “OEM licenses are efficient[.] [read post]
27 Oct 2021, 5:15 am by Dennis Crouch
Federal Trade Commission, No. 21-406 (reverse payment patent settlement). [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]